Literature DB >> 6796009

Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.

J S Dixon, M E Pickup, H A Bird, M R Lee, V Wright, W W Downie.   

Abstract

Biochemical and clinical changes have been monitored in 30 patients with rheumatoid arthritis treated with either hydroxychloroquine or sodium aurothiomalate over a period of 6 months. Acute-phase reactants improved in both treatment groups, while serum sulphydryl and serum histidine improved only in the gold-treated patients. Correlation matrices were constructed from mean clinical and biochemical data at successive clinic visits. Correlations obtained with gold were more frequent and of a higher level of significance than those obtained with hydroxychloroquine at the doses we studied. This lends support to the use of correlation matrices as a screening test for potential long-term antirheumatoid activity of drugs in man.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796009      PMCID: PMC1000785          DOI: 10.1136/ard.40.5.480

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis.

Authors:  E B HAMILTON; J T SCOTT
Journal:  Arthritis Rheum       Date:  1962-10

2.  Antirheumatic drugs, the ESR, and the hypohistidinemia of rheumatoid arthritis.

Authors:  D A Gerber
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

3.  The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.

Authors:  B McConkey; R A Crockson; A P Crockson; A R Wilkinson
Journal:  Q J Med       Date:  1973-10

Review 4.  An appraisal of chloroquine.

Authors:  A H Mackenzie
Journal:  Arthritis Rheum       Date:  1970 May-Jun

5.  On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum.

Authors:  M E Pickup; J S Dixon; H A Bird
Journal:  J Pharm Pharmacol       Date:  1980-04       Impact factor: 3.765

6.  Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.

Authors:  J S Dixon; M E Pickup; J R Lowe; C Hallett; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

7.  Is chloroquine obsolete in treatment of rheumatic disease?

Authors:  J S Marks; B J Power
Journal:  Lancet       Date:  1979-02-17       Impact factor: 79.321

8.  A biochemical comparison of alclofenac and D-penicillamine in rheumatoid arthritis.

Authors:  H A Bird; J S Dixon; M E Pickup; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

  8 in total
  7 in total

1.  How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?

Authors:  J S Dixon; M Greenwood; H A Bird
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

2.  A comparison of prednisolone with azathioprine and prednisolone with intramuscular gold in rheumatoid arthritis.

Authors:  H Häntzschel; W Otto; S Arnold; W Seidel; W Krüger; P Winiecki; H A Bird; J S Dixon; G Astbury; V Wright
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

3.  Oral gold for rheumatoid arthritis.

Authors:  V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-06

4.  Serum biochemistry in relation to the action of azathioprine in rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; N G Sitton; M E Pickup; P A Leatham; V Wright
Journal:  Agents Actions       Date:  1983-06

5.  Black phosphorus-Au-thiosugar nanosheets mediated photothermal induced anti-tumor effect enhancement by promoting infiltration of NK cells in hepatocellular carcinoma.

Authors:  Changchang Jia; Fan Zhang; Jiamei Lin; Liwen Feng; Tiantian Wang; Yuan Feng; Feng Yuan; Yang Mai; Xiaowei Zeng; Qi Zhang
Journal:  J Nanobiotechnology       Date:  2022-02-21       Impact factor: 10.435

Review 6.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

Review 7.  A 21st Century Evil: Immunopathology and New Therapies of COVID-19.

Authors:  Taylon Felipe Silva; Fernanda Tomiotto-Pellissier; Raquel Arruda Sanfelice; Manoela Daiele Gonçalves; Bruna Taciane da Silva Bortoleti; Mariana Barbosa Detoni; Ana Carolina Jacob Rodrigues; Amanda Cristina Machado Carloto; Virgínia Márcia Concato; Elaine da Silva Siqueira; Idessania Nazareth Costa; Wander Rogério Pavanelli; Ivete Conchon-Costa; Milena Menegazzo Miranda-Sapla
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.